FDA Inspection 1151122 — Medartis Inc.

Medartis Inc. — FEI 3009540749

The FDA completed an inspection of Medartis Inc. on Sep 3, 2021 in Warsaw, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 3, 2021
Fiscal Year
2021
Product Type
Devices
Project Area
Compliance: Devices
Location
Warsaw, IN (United States)

Citations

IDCFRDescription
312821 CFR 820.90(a)Nonconforming product control
317221 CFR 820.198(c)Investigation of device failures
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.